More NewsRead More
RedHill Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
September 04, 2014
RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis
September 03, 2014
RedHill Biopharma Provides Update on Expansion of Ongoing RHB-105 Phase III Study, Targeting Broadened H. pylori Indication Authorized by FDA
August 27, 2014
RedHill Biopharma to Host Second Quarter 2014 Financial Results Conference Call on July 24, 2014
July 16, 2014
RedHill Biopharma Announces Positive Preliminary Pre-Clinical Data With RHB-104 for the Treatment of Type 1 Diabetes
June 26, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here